Connective tissue growth factor production by activated pancreatic stellate cells in mouse alcoholic chronic pancreatitis.
Alcoholic chronic pancreatitis (ACP) is characterized by pancreatic necrosis, inflammation, and scarring, the latter of which is due to excessive collagen deposition by activated pancreatic stellate cells (PSC). The aim of this study was to establish a model of ACP in mice, a species that is usually resistant to the toxic effects of alcohol, and to identify the cell type(s) responsible for production of connective tissue growth factor (CTGF), a pro-fibrotic molecule. C57Bl/6 male mice received intraperitoneal ethanol injections for 3 weeks against a background of cerulein-induced acute pancreatitis. Peak blood alcohol levels remained consistently high in ethanol-treated mice as compared with control mice. In mice receiving ethanol plus cerulein, there was increased collagen deposition as compared with other treatment groups as well as increased frequency of alpha-smooth muscle actin and desmin-positive PSC, which also showed significantly enhanced CTGF protein production. Expression of mRNA for collagen alpha1(I), alpha-smooth muscle actin or CTGF were all increased and co-localized exclusively to activated PSC in ACP. Pancreatic expression of mRNA for key profibrotic markers were all increased in ACP. In conclusion, a mouse model of ACP has been developed that mimics key pathophysiological features of the disease in humans and which shows that activated PSC are the principal producers of collagen and CTGF. PSC-derived CTGF is thus a candidate therapeutic target in anti-fibrotic strategies for ACP.
Charrier
Alyssa L
AL
Center for Clinical and Translational Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
Brigstock
David R
DR
D057229:Alcoholics; D000437:Alcoholism / Q000378:metabolism / Q000473:pathology; D000818:Animals; D002108:Ceruletide / Q000378:metabolism / Q000494:pharmacology; D003094:Collagen / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology; D055513:Connective Tissue Growth Factor; D000431:Ethanol / Q000378:metabolism / Q000494:pharmacology; D005109:Extracellular Matrix / Q000378:metabolism; D005355:Fibrosis / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology*; D010195:Pancreatitis / Q000378:metabolism / Q000473:pathology*; D019512:Pancreatitis, Alcoholic / Q000378:metabolism* / Q000473:pathology; D050500:Pancreatitis, Chronic / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism / Q000494:pharmacology
D012333:RNA, Messenger; D055513:Connective Tissue Growth Factor; D000431:Ethanol; D002108:Ceruletide; D003094:Collagen